A treatment pioneered at the University of Pittsburgh Center for Vaccine Research (CVR) is far more effective than traditional antibiotics at inhibiting the growth of drug-resistant bacteria, including so-called “superbugs” resistant to almost all existing antibiotics, which plague hospitals and nursing homes.
The findings, announced online in the journal Antimicrobial Agents and Chemotherapy and funded by the National Institutes of Health, provide a needed boost to the field of antibiotic development, which has been limited in the last four decades and outpaced by the rise of drug-resistant bacterial strains.
“Very few, if any, medical discoveries have had a larger impact on modern medicine than the discovery and development of antibiotics,” said senior author Ronald C. Montelaro, Ph.D., professor and co-director of Pitt’s CVR. “However, the success of these medical achievements is being threatened due to increasing frequency of antibiotic resistance. It is critical that we move forward with development of new defenses against the drug-resistant bacteria that threaten the lives of our most vulnerable patients.”
Each year in the U.S., at least 2 million people are infected with drug-resistant bacteria, and at least 23,000 die as a direct result of these infections, according to the U.S. Centers for Disease Control and Prevention.
On the tail end of HIV surface protein, there is a sequence of amino acids that the virus uses to “punch into” and infect cells. Dr. Montelaro and his colleagues developed a synthetic and more efficient version of this sequence – called engineered cationic antimicrobial peptides, or “eCAPs”—that can be chemically synthesized in a laboratory setting.< The team tested the two leading eCAPs against a natural antimicrobial peptide (LL37) and a standard antibiotic (colistin), the latter being used as a last-resort antibiotic against multidrug resistant bacterial infections. The scientists performed the tests in a laboratory setting using 100 different bacterial strains isolated from the lungs of pediatric cystic fibrosis patients of Seattle Children’s Hospital and 42 bacterial strains isolated from hospitalized adult patients at UPMC.
The natural human antimicrobial peptide LL37 and the colistin drug each inhibited growth of about 50 percent of the clinical isolates, indicating a high level of bacterial resistance to these drugs. In marked contrast, the two eCAPS inhibited growth in about 90 percent of the test bacterial strains.
The Latest on: Antibiotic-Resistant Superbugs
via Google News
The Latest on: Antibiotic-Resistant Superbugs
- Superbugs are here to stayon November 20, 2019 at 12:21 pm
The CDC has told us that superbugs and wider drug resistance is already here ... need to be cleaner and medical practices better to prevent the spread of antibiotic-resistant pathogens. But two ...
- Intermountain leading national charge against antibiotic overuse, 'superbugs'on November 20, 2019 at 12:40 am
Last week, the CDC released its 2019 antibiotic resistance threat report, which said antibiotic resistant bacteria, or superbugs, infect 2.9 million people each year in the U.S., killing 35,000.
- Health officials warn of antibiotic-resistant 'superbugs'on November 18, 2019 at 7:32 pm
Health officials are spreading the word: Lay off the antibiotics when possible, to avoid fueling the spread of antibiotic-resistant “superbugs.” The North Dakota Department of Health, echoing health ...
- Superbug battle: Bacteria structure may be key to new antibioticson November 18, 2019 at 1:52 pm
As the threat of antibiotic-resistant germs grows, this discovery offers hope for finding an alternative way to target disease-causing bacteria. In the study, researchers used X-ray crystallography to ...
- Viral ‘Smart Bombs’ Are Becoming Weapons Against Superbugson November 18, 2019 at 2:00 am
At the University of California at San Diego and elsewhere around the world, researchers and drugmakers are betting that so-called phage therapy can help close the growing gaps in medical treatment ...
- Superbugs could kill us all if we’re not carefulon November 16, 2019 at 11:11 am
Today, antibiotic-resistant bacteria are already claiming lives, and a new report from the Centers for Disease Control and Prevention reveals that as many as four people are killed by these new ...
- Drug-resistant superbugs are killing thousands of Americans. Here's what you need to know about themon November 16, 2019 at 8:52 am
... come in with a set of symptoms and the doctor must figure out their risk for a superbug. Doctors must look through a person's medical history and travel records when determining if the person's ...
- CDC: The number of Americans dying from antibiotic-resistant "superbugs" vastly underestimatedon November 14, 2019 at 4:09 pm
Twice as many people are dying from antibiotic-resistant infections, also known as superbugs, than previously thought, according to a report published by the Centers for Disease Control and Prevention ...
- Antibiotic-resistant superbugs kill 35K Americans each year — and CDC warns worst is yet to comeon November 14, 2019 at 11:37 am
One of the biggest issues contributing to the evolution of antibiotic-resistant superbugs is the overuse and misuse of antibiotics in both human and animal populations, which has been proven by ...
- Antibiotic-Resistant Superbugs Infect Nearly 3 Million Americans Each Year, Kill More than 35,000on November 14, 2019 at 11:27 am
A new CDC report has both good and bad news about antibiotic-resistant superbugs.
via Bing News